XOOMAR

ARDELYX, INC. (ARDX)

Every FINRA and SEC series the site collects for ARDELYX, INC.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.

Download CSV

22.7M

Short interest

settlement 2026-08-31

6.1

Days to cover

+1.3% vs prior

46.7%

Short share of volume

2026-09-11

19,315

Fails to deliver

settlement 2026-08-13

-$1.2M

Insider flow, 90 days

0 buys, 23 sells

As of 2026-09-11.

Short interest

FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSON

As of 31 August 2026, short interest in ARDX is 22,716,201 shares, down 3,523,025 shares over the last month. Over the last 48 readings it ranged from 18,557,299 shares (30 January 2026) to 30,644,481 shares (31 March 2025). At the reported average volume of 3.7M shares a day that is 6.1 days to cover, elevated.

Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/ardx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-08-3122,716,201+1.3%3,702,4786.14
2026-08-1422,433,157-14.5%6,766,7013.32
2026-07-3126,239,226-0.0%2,384,53111.00
2026-07-1526,248,733+3.5%3,255,4738.06
2026-06-3025,366,491-5.8%6,281,9164.04
2026-06-1526,942,503+8.7%3,140,7308.58
2026-05-2924,776,898+3.9%2,562,3049.67
2026-05-1523,857,367+1.2%5,247,6944.55
2026-04-3023,569,074-1.9%3,228,1357.30
2026-04-1524,018,325-1.8%3,127,2257.68
2026-03-3124,462,758+12.7%3,591,0166.81
2026-03-1321,701,321-0.8%2,898,4227.49
2026-02-2721,868,223+6.6%5,349,8914.09
2026-02-1320,520,612+10.6%3,073,1126.68
2026-01-3018,557,299-15.0%4,965,9033.74
2026-01-1521,833,586-11.0%8,076,8552.70
2025-12-3124,541,228+18.8%2,775,3888.84
2025-12-1520,664,408+2.8%2,774,1977.45
2025-11-2820,101,736+8.3%2,656,1517.57
2025-11-1418,568,868-8.2%3,628,0555.12
2025-10-3120,225,907+5.8%4,557,4924.44
2025-10-1519,112,230-1.9%3,476,5895.50
2025-09-3019,480,138-1.4%3,149,7426.18
2025-09-1519,764,866-7.9%3,265,0646.05

Daily short volume

FINRA Reg SHO, last 60 sessions. JSON

As of 11 September 2026, the short share of ARDX volume is 46.7%, up 2.2 points over the last five sessions. Over the last 52 readings it ranged from 27.4% (10 August 2026) to 67.4% (21 July 2026). The latest reading is in line with the 30-session average of 45.3%, on 2.0M shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-09-11935K2.0M46.7%510
2026-09-10884K1.7M52.2%2,298
2026-09-09980K1.9M51.0%2,691
2026-09-08541K1.2M44.4%833
2026-09-04704K1.6M44.6%50
2026-09-03813K1.8M44.5%1,693
2026-09-02762K1.9M40.9%75
2026-09-01355K809K43.9%10
2026-08-31809K1.6M51.4%186
2026-08-281.3M2.2M57.1%10,501
2026-08-27502K933K53.9%0
2026-08-26450K1.3M35.2%958
2026-08-25419K1.3M31.6%13,989
2026-08-241.9M3.0M63.9%497,333
2026-08-21608K1.3M48.4%10,527
2026-08-20670K1.9M35.2%7,055
2026-08-19421K1.2M36.4%0
2026-08-18780K1.8M44.1%53,727
2026-08-17522K1.3M38.8%6,520
2026-08-14789K2.1M37.6%0
2026-08-13850K2.0M43.0%14,701
2026-08-12677K2.1M32.1%13,192
2026-08-111.5M3.8M40.1%3,900
2026-08-101.6M5.7M27.4%79,227
2026-08-074.1M9.7M42.0%302,507
2026-08-06984K1.9M52.0%3,136
2026-08-05561K1.1M53.4%555
2026-08-04781K1.3M59.1%318
2026-08-03498K1.1M44.9%5,979
2026-07-31656K1.0M62.6%158

Fails to deliver

SEC, by settlement date. JSON

As of 13 August 2026, the fails-to-deliver balance in ARDX is 19,315 shares, up 18,558 shares over the last settlement date. Over the last 52 readings it ranged from 6 shares (12 August 2025) to 711,463 shares (25 March 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-08-1319,315$3.97$77K
2026-07-22757$5.09$4K
2026-07-2110,122$5.09$52K
2026-07-17300$5.13$2K
2026-07-021,990$5.16$10K
2026-06-186,258$5.84$37K
2026-06-0865,616$5.56$365K
2026-06-031,357$5.52$7K
2026-05-221,789$6.35$11K
2026-05-193,656$6.11$22K
2026-05-1875$6.23$467
2026-05-1316,357$6.61$108K
2026-05-042,755$6.88$19K
2026-04-152,490$6.33$16K
2026-04-021,811$6.11$11K
2026-03-30487$5.48$3K
2026-03-27328$5.69$2K
2026-03-25711,463$5.35$3.8M
2026-03-2043,291$5.50$238K
2026-03-19334$5.55$2K
2026-03-135,147$5.66$29K
2026-02-253,009$6.56$20K
2026-02-245,861$5.75$34K
2026-02-172,839$6.87$20K
2026-02-132,903$7.01$20K
2026-02-0956$7.32$410
2026-02-037,406$7.79$58K
2026-01-2840,449$7.89$319K
2026-01-05476$6.15$3K
2025-12-311,107$5.80$6K

Insider trades

SEC Form 4, newest first, 50 of 100 shown. JSON

Insiders at ARDX reported 23 open-market sells worth $1.2M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Hohenleitner Susan (Chief Financial Officer) on 2026-08-21.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-08-21Hohenleitner SusanChief Financial OfficerSell2K$3.86$6K228K
2026-08-21Brady James ParkerChief Human Resources OfficerSell13K$3.86$51K246K
2026-08-21Brady James ParkerChief Human Resources OfficerSell2K$3.86$8K259K
2026-08-21Reilly Joseph JamesSee RemarksSell1K$3.86$4K146K
2026-08-21Reilly Joseph JamesSee RemarksSell3K$3.86$11K147K
2026-08-21Foster Eric DuaneChief Commercial OfficerSell3K$3.86$10K409K
2026-08-21Foster Eric DuaneChief Commercial OfficerSell3K$3.86$13K412K
2026-08-21Foster Eric DuaneChief Commercial OfficerSell3K$3.86$10K415K
2026-08-21Kelliher MikeChief Business OfficerSell2K$3.86$8K350K
2026-08-21Kelliher MikeChief Business OfficerSell3K$3.86$10K352K
2026-08-21Kelliher MikeChief Business OfficerSell3K$3.86$12K354K
2026-08-21Williams Laura AChief Patient OfficerSell2K$3.86$7K367K
2026-08-21Williams Laura AChief Patient OfficerSell2K$3.86$9K369K
2026-08-21Williams Laura AChief Patient OfficerSell3K$3.86$12K372K
2026-08-21Williams Laura AChief Patient OfficerSell3K$3.86$13K375K
2026-08-21RAAB MICHAELPresident &amp; CEOSell19K$3.86$74K1.6M
2026-08-21RAAB MICHAELPresident &amp; CEOSell8K$3.86$32K1.6M
2026-08-21RAAB MICHAELPresident &amp; CEOSell16K$3.86$62K1.6M
2026-08-21RAAB MICHAELPresident &amp; CEOSell15K$3.86$58K1.7M
2026-08-21Bishop John ESee RemarksSell2K$3.86$10K317K
2026-08-21Bishop John ESee RemarksSell17K$3.86$67K320K
2026-07-15RAAB MICHAELPresident &amp; CEOSell42K$5.06$211K1.7M
2026-07-15RAAB MICHAELPresident &amp; CEOOption exercise21K$0.99$21K1.7M
2026-06-18Williams Laura AChief Patient OfficerSell82K$5.99$490K378K
2026-06-18Williams Laura AChief Patient OfficerOption exercise31K$0.99$31K460K
2026-06-16Bhanji Munan/aGrant26K$0.00$0164K
2026-06-16Cadoret-Manier Onaizan/aGrant26K$0.00$0178K
2026-06-16Parsey Merdadn/aGrant26K$0.00$084K
2026-06-16Bazemore Robert Bn/aGrant26K$0.00$068K
2026-06-16Rodgers Richard Jn/aGrant26K$0.00$0440K
2026-06-16Bertrand William C JRn/aGrant26K$0.00$0330K
2026-06-16Bertrand William C JRn/aGrant12K$0.00$0303K
2026-06-16MOTT DAVID Mn/aGrant26K$0.00$03.3M
2026-06-16MOTT DAVID Mn/aGrant20K$0.00$03.3M
2026-06-15RAAB MICHAELPresident &amp; CEOSell42K$5.67$236K1.7M
2026-06-15RAAB MICHAELPresident &amp; CEOOption exercise21K$0.99$21K1.7M
2026-05-21Hohenleitner SusanChief Financial OfficerSell1K$6.27$9K229K
2026-05-21Brady James ParkerChief Human Resources OfficerSell2K$6.27$12K261K
2026-05-21Reilly Joseph JamesSee RemarksSell1K$6.27$6K150K
2026-05-21Reilly Joseph JamesSee RemarksSell3K$6.27$17K149K
2026-05-21Foster Eric DuaneChief Commercial OfficerSell2K$6.27$15K418K
2026-05-21Foster Eric DuaneChief Commercial OfficerSell2K$6.27$15K420K
2026-05-21Foster Eric DuaneChief Commercial OfficerSell3K$6.27$20K423K
2026-05-21Kelliher MikeChief Business OfficerSell2K$6.27$16K357K
2026-05-21Kelliher MikeChief Business OfficerSell2K$6.27$12K360K
2026-05-21Kelliher MikeChief Business OfficerSell3K$6.27$18K362K
2026-05-21Williams Laura AChief Patient OfficerSell1K$6.27$9K429K
2026-05-21Williams Laura AChief Patient OfficerSell2K$6.27$12K431K
2026-05-21Williams Laura AChief Patient OfficerSell2K$6.27$14K432K
2026-05-21Williams Laura AChief Patient OfficerSell2K$6.27$9K435K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.

Planned sales (Form 144)

Newest first. JSON

8 Form 144 notices on file for ARDX worth $524K at the prices reported; 8 in the last 90 days worth $524K. Latest: Hohenleitner Susan filed on 2026-08-21 to sell 2,650 shares ($11K) from 2026-08-21.

FiledSellerSharesMarket valueOf outstandingSale fromBroker
2026-08-21Hohenleitner SusanOfficer3K$11K0.001%2026-08-21Morgan Stanley Smith Barney LLC Executive Financial Services
2026-08-21Brady James ParkerOfficer20K$79K0.008%2026-08-21Morgan Stanley Smith Barney LLC Executive Financial Services
2026-08-21Reilly Joseph JamesOfficer5K$19K0.002%2026-08-21Morgan Stanley Smith Barney LLC Executive Financial Services
2026-08-21Foster Eric DuaneOfficer12K$48K0.005%2026-08-21Morgan Stanley Smith Barney LLC, Executive Financial Services
2026-08-21Kelliher MikeOfficer11K$42K0.004%2026-08-21Morgan Stanley Smith Barney LLC Executive Financial Services
2026-08-21Williams Laura AOfficer11K$42K0.004%2026-08-21Morgan Stanley Smith Barney LLC Executive Financial Services
2026-08-21RAAB MICHAELOfficer45K$179K0.018%2026-08-21Morgan Stanley Smith Barney LLC Executive Financial Services
2026-08-21Bishop John EOfficer26K$103K0.010%2026-08-21Morgan Stanley Smith Barney LLC Executive Financial Services

Large holders (13D and 13G)

One row per reporting person, newest filing first. JSON

8 holders above 5% have filed on ARDX, all on Schedule 13G (passive). The largest reported stake is Rubric Capital Management LP at 6.6% of the class (16,202,700 shares), filed 2026-08-14 for an event on 2026-06-30.

FiledFormHolderSharesOf classEvent
2026-08-1413GRubric Capital Management LPinvestment adviser, partnership16.2M6.6%2026-06-30
2026-08-1413GDavid Rosenparent holding company, individual16.2M6.6%2026-06-30
2026-08-1113G/Ano. 2Millennium Management LLCother entity14.2M5.7%2026-06-30
2026-08-1113G/Ano. 2Millennium Group Management LLCother entity14.2M5.7%2026-06-30
2026-08-1113G/Ano. 2Israel A. Englanderindividual14.2M5.7%2026-06-30
2026-08-1113G/Ano. 2Integrated Core Strategies (US) LLCother entity12.0M4.8%2026-06-30
2026-03-2613G/Ano. 3The Vanguard Groupinvestment adviser00.0%2026-03-13
2026-01-3013G/Ano. 2The Vanguard Groupinvestment adviser19.0M7.8%2025-12-31
2026-01-1213GIsrael A. Englanderindividual13.1M5.4%2026-01-05
2026-01-1213GMillennium Management LLCother entity13.1M5.4%2026-01-05
2026-01-1213GMillennium Group Management LLCother entity13.1M5.4%2026-01-05
2026-01-1213GIntegrated Core Strategies (US) LLCother entity12.9M5.3%2026-01-05
2025-11-1413G/Ano. 8JANUS HENDERSON GROUP PLCinvestment adviser, parent holding company13.8M5.7%2025-09-30
2025-10-2813G/Ano. 1Millennium Management LLCother entity7.7M3.2%2025-09-30
2025-10-2813G/Ano. 1Israel A. Englanderindividual7.7M3.2%2025-09-30
2025-10-2813G/Ano. 1Millennium Group Management LLCother entity7.7M3.2%2025-09-30

13F holders

Tracked managers holding ARDX at their latest 13F. JSON

6 of the 30 tracked managers held ARDX at their latest 13F, $123.0M in total at quarter-end prices. Millennium Management is the largest at $72.8M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 5 cut.

FundQuarterSharesValueOf portfolioChange in shares
Millennium Management2026-06-3014.3M$72.8M0.03%-3.8M
Two Sigma Investments2026-06-305.2M$26.6M0.02%+936K
AQR Capital Management2026-06-302.3M$11.8M0.00%-123K
Citadel Advisors2026-06-301.4M$7.2M0.00%-2.3M
Renaissance Technologies2026-06-30893K$4.6M0.01%-380K
D. E. Shaw & Co.2026-06-3013K$67K0.00%-301K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In Q2 2026 (quarter ended 2026-06-30) ARDELYX, INC. reported revenue of $120.9M, up 23.8% from the same quarter a year earlier, and net loss of $16.7M (-0.07 diluted EPS). In FY 2025 it generated -$42.5M of operating cash flow. As of 2026-06-30, cash was $97.2M against $251.8M of debt.

Cash
$97.2M
Debt
$251.8M
Equity
$149.0M
Total assets
$575.9M
Shares outstanding
249,187,572

Quarterly, last 8 quarters

QuarterPeriod endRevenueNet incomeMarginDiluted EPS
Q2 20262026-06-30$120.9M-$16.7M-13.8%-0.07
Q1 20262026-03-31$94.5M-$37.6M-39.8%-0.15
Q4 2025derived2025-12-31$125.2Mn/an/an/a
Q3 20252025-09-30$110.3M-$969K-0.9%0.00
Q2 20252025-06-30$97.7M-$19.1M-19.5%-0.08
Q1 20252025-03-31$74.1M-$41.1M-55.5%-0.17
Q4 2024derived2024-12-31$116.1Mn/an/an/a
Q3 20242024-09-30$98.2M-$809K-0.8%0.00

Fiscal years, with buybacks and dividends

Fiscal yearEndsRevenueNet incomeOperating cash flowCapexBuybacksDividends
FY 20252025-12-31$407.3Mn/a-$42.5M$1.5Mn/an/a
FY 20242024-12-31$333.6Mn/a-$44.8M$1.0Mn/an/a
FY 20232023-12-31$124.5Mn/a-$89.7M$344Kn/an/a
FY 20222022-12-31$52.2Mn/a-$70.0M$55Kn/an/a
FY 20212021-12-31$10.1Mn/a-$152.6M$1.9Mn/an/a

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-30 from the cover page.

What this page is

ARDELYX, INC. in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.

This page follows ARDELYX, INC. (ARDX), SEC CIK 1437402, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and method

Short interest
FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-13.JSON and CSV
Planned sales
SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-08-21.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-14.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Financials
SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
Insider trades
SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-08-21.JSON and CSV
Company record
EDGAR filing index for CIK 1437402Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
30 requests a minute without a key, 120 a minute with a key from a free account.

Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 14 Sep 05:40 UTC.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of ARDX is sold short?
22,716,201 shares were held short at the 2026-08-31 settlement, 6.1 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is ARDX's daily short volume?
On 2026-09-11, 935,063 of the 2,003,953 ARDX shares reported to FINRA were sold short, 46.7% of the day's reported volume. Short volume is a flow for one day, not a position.
Does ARDX have fails to deliver?
The SEC's latest file shows 19,315 ARDX shares failed to deliver at settlement 2026-08-13. Fails are reported per settlement date and published twice a month with a lag.
Are ARDX insiders buying or selling?
Insiders at ARDX reported 23 open-market sells worth $1.2M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Hohenleitner Susan (Chief Financial Officer) on 2026-08-21.
Have ARDX insiders filed to sell?
8 Form 144 notices on file for ARDX worth $524K at the prices reported; 8 in the last 90 days worth $524K. Latest: Hohenleitner Susan filed on 2026-08-21 to sell 2,650 shares ($11K) from 2026-08-21.
Who owns more than 5% of ARDX?
8 holders above 5% have filed on ARDX, all on Schedule 13G (passive). The largest reported stake is Rubric Capital Management LP at 6.6% of the class (16,202,700 shares), filed 2026-08-14 for an event on 2026-06-30.
What did ARDX report last quarter?
In Q2 2026 (quarter ended 2026-06-30) ARDELYX, INC. reported revenue of $120.9M, up 23.8% from the same quarter a year earlier, and net loss of $16.7M (-0.07 diluted EPS). In FY 2025 it generated -$42.5M of operating cash flow. As of 2026-06-30, cash was $97.2M against $251.8M of debt.
Which funds hold ARDX?
6 of the 30 tracked managers held ARDX at their latest 13F, $123.0M in total at quarter-end prices. Millennium Management is the largest at $72.8M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 1 added shares and 5 cut.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.